Posted on 08/27/20
| News Source: MATZAV
Abbott Laboratories has been given the greenlight by the Food and Drug Administration for an emergency use authorization for its $5 rapid antigen test for the coronavirus.
The test, called the BinaxNOW COVID-19 Ag Card, is roughly the size of a credit card and is administered by a healthcare professional using a nasal swab. BinaxNow uses lateral flow technology, similar to an at-home pregnancy test, to search for virus proteins and is intended to be used for patients within seven days of feeling coronavirus symptoms. The test can provide results in up to 15 minutes.
According to Abbott, the test has a demonstrated sensitivty, or the percent of positive cases that it can accurately detect, of about 97%.
Read more at Fox Business.